UA87631C2 - Complex antiischemic preparation - Google Patents
Complex antiischemic preparationInfo
- Publication number
- UA87631C2 UA87631C2 UAA200807319A UAA200807319A UA87631C2 UA 87631 C2 UA87631 C2 UA 87631C2 UA A200807319 A UAA200807319 A UA A200807319A UA A200807319 A UAA200807319 A UA A200807319A UA 87631 C2 UA87631 C2 UA 87631C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antiischemic
- complex
- preparation
- amount
- acceptable salt
- Prior art date
Links
- 230000002253 anti-ischaemic effect Effects 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- XKLMZUWKNUAPSZ-UHFFFAOYSA-N N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide Chemical compound COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC=2C(=CC=CC=2C)C)CC1 XKLMZUWKNUAPSZ-UHFFFAOYSA-N 0.000 abstract 1
- UHWVSEOVJBQKBE-UHFFFAOYSA-N Trimetazidine Chemical compound COC1=C(OC)C(OC)=CC=C1CN1CCNCC1 UHWVSEOVJBQKBE-UHFFFAOYSA-N 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 229960000213 ranolazine Drugs 0.000 abstract 1
- 229960001177 trimetazidine Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine and regards to a complex antiischemic preparation based on fatty acid oxidation blockers, which contains a pharmaceutical acceptable salt of trimetazidine in the amount from 10 mg to 500 mg and pharmaceutical acceptable salt of ranolazine in the amount from 100 mg to 3000 mg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA200807319A UA87631C2 (en) | 2008-05-27 | 2008-05-27 | Complex antiischemic preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA200807319A UA87631C2 (en) | 2008-05-27 | 2008-05-27 | Complex antiischemic preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA87631C2 true UA87631C2 (en) | 2009-07-27 |
Family
ID=50633006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200807319A UA87631C2 (en) | 2008-05-27 | 2008-05-27 | Complex antiischemic preparation |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA87631C2 (en) |
-
2008
- 2008-05-27 UA UAA200807319A patent/UA87631C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500216B1 (en) | Stable pharmaceutical composition and methods of using same | |
| HRP20160953T1 (en) | Aqueous pharmaceutical compositions containing borate-polyol complexes | |
| MY205872A (en) | Pharmaceutical compositions comprising omega-3 fatty acids | |
| EP2576578A4 (en) | Polymorphs of 2'-o-fucosyllactose and producing thereof | |
| TW201711676A (en) | Ferric citrate dosage forms | |
| EP2536736A4 (en) | Production of 6'-o-sialyllactose and intermediates | |
| IL220679A (en) | Production method of solid preparations containing alkaline active pharmaceutical ingredients and the solid preparations produced by the method | |
| MX2012003555A (en) | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same. | |
| PL2254549T3 (en) | Aqueous pharmaceutical compositions containing borate-polyol complexes | |
| MX2011011858A (en) | Borinic compositions. | |
| EP3228311A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
| PH12014502856A1 (en) | Solid pharmaceutical preparation containing levothyroxine | |
| IN2014CN03214A (en) | ||
| TN2012000507A1 (en) | Enteric tablet | |
| MX2012002631A (en) | Scented capsules. | |
| MX349563B (en) | Pharmaceutical formulation of nanonised fenofibrate. | |
| UA87631C2 (en) | Complex antiischemic preparation | |
| WO2012111961A3 (en) | Orally administrated sustained-release tablet containing tianeptine or pharmaceutically acceptable salt thereof | |
| WO2011161247A3 (en) | Dental care chewing gum comprising silver moieties | |
| EA201291118A1 (en) | NUTRITSEVTICHESKIE AND PHARMACEUTICAL COMPOSITIONS COATED IN A CHEWABLE GUM SHEET | |
| IT1394710B1 (en) | COMPOSITION FOR A NATURAL FOOD SUPPLEMENT, PARTICULARLY TO ENCOURAGE THE PHYSIOLOGICAL FUNCTIONALITY OF THE LIVER. | |
| UA19962S (en) | DISPLAY OF THE PACKAGING OF DIETARY SUPPLEMENT "NOODI-DA" "HUDI-DA" (CAPSULES) | |
| AU2016219657A1 (en) | Stable pharmaceutical composition and methods of using same | |
| AU2008903521A0 (en) | Artificial inseminator H.I.V. drugs & lemons & others sex safety babies H.I.V. drugs | |
| WO2012078121A3 (en) | Solid oral dosage form comprising cefdinir |